Clinical Trials Browser

Phase 1/2 × NETWORK × Hydroxychloroquine × Clear all

NCT04201457 2026-02-03

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

Phase 1/2 Active not recruiting

Glioma